ReviewPharmaceuticals (Basel, Switzerland)2026

Targeting HMGB1 for Renal Ischemia and Reperfusion Injury: Mechanisms and Therapeutic Strategies.

Xiao-Hui Chi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.